Concern is that in the Chinese medicine industry tend to pick up the trend of exports under the setting as Korea, technical barriers to trade, China Chinese crude drugs, extracts, and health care products on the South Korean exports dropped significantly. This situation has caused companies to pay attention, a new coping emerging?? Part of the Chinese Herbal Medicine enterprises through the establishment of alliances to achieve Baotuan exports to reverse the trend.
Prominent phenomenon limits the exporting country Chinese Chamber of Commerce, according to Medicare Part
deputy Ren Luoyang introduced from 1 August this year, the global Financial crisis The impact of sharp drop in China’s foreign trade import and export value of 22.4 percent, exports decreased by 22.2 percentage points. The pharmaceutical industry as a unique industry with rigid demand, although it is under attack, but overall development remained optimistic about the Chinese sub-sectors of the economy from the point of view, especially warmer.
Statistics show that 1 in August this year, Chinese commodities import and export volume reached 1.23 billion U.S. dollars, a record high, up 7.5%; of which, imports amounted to 350 million U.S. dollars, up 19.6%; exports 880 million U.S. dollars, up 3.5%. From the sub-field of view, 1 August, China’s export growth of plant extracts particularly attractive is the only year Chinese class a substantial increase in exports of goods; proprietary Chinese medicines, herbs and slices of performance is relatively less.
1 August this year, total import and export of Chinese crude drugs accumulated 160,000 tons, down 9.2% year on year, import and export amounted to 370 million U.S. dollars, down 5%. Among them, the export of 130,000 tons, down 8.9% year on year, exports 310 million U.S. dollars, down 8.5%; import 30,000 tons, down 11%, imports amounted to 060 million U.S. dollars, up 18%.
Although herbal medicines and Pieces 1 to August compared with the decline in exports last year obviously, but from quarter to analyze the situation is different: the first quarter, export volume dropped 22.6%, but a distinctly smaller decline in the second quarter, only 3.1%; and 7 in August of this year compared to last year, the export amount has been reversed to an increase of 4%, exports pick up signs of obvious. At the time, our Chinese crude drugs were the major export markets ranked Hong Kong, China, Japan, Vietnam, Korea, China Taiwan; the same time, strong growth in the Latin American market demand, but exports fell more in Europe.
“2009 1 ~ in August, with the national large-scale Economy The emerging role of stimulus measures, the global economy in general show ‘Xianyihouyang’ characteristics. Many countries to accelerate the economic decline temporarily ended the early momentum into the recovery from the recession to the crucial stage of the world demand for Chinese medicine gradually restored. “Health Insurance Association vice president of Liuzhang Lin said.
Despite signs of warming, but the Chinese commodities in the export market remains limited issue of concern at the meeting. Due to South Korea to set technical barriers to trade restrictions, China Chinese crude drugs, extracts and health care products export to South Korea this year was substantially reduced. It is understood that South Korea’s heavy metal content in Chinese Herbal Medicine, Pesticide Residual issues such as setting up a host of obstacles. Relying on brand strengths
Grim situation spawned a new model. “In the current trade situation, the enterprise must work together, to deal with international markets.” Lotus Chinese Herbal Medicine Co., Ltd. Sichuan New Chairman Jiang Yun to “Medicine Economic News,” told reporters.
Reporter learned that the new Lotus is now a six slices joint enterprise, through the alliance in the form of division of labor, finally relying on the brand new Lotus co-exported to South Korea.
Posted in 
